目的：探讨玻璃酸钠滴眼液联合维生素A棕榈酸酯眼用凝胶对干眼症患者的治疗效果、泪膜稳定性及炎症因子水平的影响。

方法：选取2015-01/2017-02在我院治疗的100例120眼干眼症患者，随机分为对照组和观察组，每组50例60眼，对照组患者给予玻璃酸钠滴眼液治疗，观察组患者在对照组的基础上给予维生素A棕榈酸酯眼用凝胶，对两组患者临床疗效、泪膜稳定性及炎症因子水平进行评价。

结果：治疗后，两组患者BUT及SⅠt水平均较治疗前显著上升，FL较治疗前显著降低，观察组治疗后BUT及SⅠt水平分别为11.24±0.22s及11.4±0.17mm/5min，显著高于对照组治疗后，FL水平为1.78±0.10分，显著低于对照组治疗后，差异有统计学意义(P<0.05)； 治疗后，两组患者IL-1β及TNF-α水平均显著降低，观察组治疗后IL-1β及TNF-α水平分别为34.38±5.58ng/L及134.47±12.14ng/L，显著低于对照组治疗后，差异有统计学意义(P<0.05)； 观察组治疗后总有效率为91.7%，显著高于对照组，差异有统计学意义(P<0.05)。

结论：玻璃酸钠滴眼液联合维生素A棕榈酸酯眼用凝胶能有效缓解干眼症患者的症状，增加泪膜稳定性，降低泪液炎症因子水平，疗效可靠。

METHODS: A total of 100 patients with dry eye treated in our hospital from January 2015 to February 2017 were randomly divided into control group and observation group, 50 cases in each group. Patients in the control group were treated with sodium hyaluronate eye drops. Patients in the observation group were given vitamin A palmitate ophthalmic gel on the basis of the control group, and then the clinical efficacy, tear film stability and the level of inflammatory cytokines were detected in the two groups.

RESULTS: After treatment, the levels of BUT and SⅠt in both groups increased significantly compared with that before treatment, and FL was significantly lower than that before treatment. The levels of BUT and SⅠt in the observation group after treatment were 11.24±0.22s and 11.4±0.17mm/5min respectively, which was high than that of control groups(P<0.05). FL level was 1.78±0.10 points, which was significantly lower than that of the control group after treatment(P<0.05). After treatment, the levels of IL-1β and TNF-αsignificantly decreased in both groups. The levels of IL-1β and TNF-α in the observation group were 34.38±5.58ng/L and 134.47±12.14ng/L, significantly lower than those of the control group after treatment, the difference was statistically significant(P<0.05). The total effective rate of observation group after treatment was 91.7%, significantly higher than that of the control group after treatment, the difference was statistically significant(P<0.05).

CONCLUSION: Sodium hyaluronate eye drops combined with vitamin A palmitate ophthalmic gel can relieve the symptoms of patients with dry eye effectively, increase the stability of tear film, and reduce the levels of inflammatory factors in tears, which is reliable in clinical application.